Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients
Background The concurrent use of sedating centrally acting drugs and opioids by chronic pain patients occurs routinely despite concerns of negative impacts on respiration during sleep. The effects of centrally acting drugs and opioids on sleep apnoea have not been well characterised. The objective o...
Main Authors: | Soodaba Mir, Jean Wong, Clodagh M. Ryan, Geoff Bellingham, Mandeep Singh, Rida Waseem, Danny J. Eckert, Frances Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2020-08-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/6/3/00093-2020.full |
Similar Items
-
Opioid Safety and Concomitant Benzodiazepine Use in End-Stage Renal Disease Patients
by: Rupam Ruchi, et al.
Published: (2019-01-01) -
Concomitant Obstructive Sleep Apnoea in Patients with Meniere’s Disease: A Case Report and Literature Review
by: Wong Kein Low, et al.
Published: (2021-01-01) -
Sleep apnoea and the heart
by: Patrick Lévy, et al.
Published: (2013-09-01) -
Sleep apnoea
by: Jonathan C. Jun, et al.
Published: (2016-03-01) -
Sleep apnoea and telemonitoring
Published: (2015-06-01)